X

Trial Profile

PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Dec 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ethyl eicosapentaenoic acid (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use
Acronyms PREPARE-IT

Most Recent Events

16 Nov 2021 According to an Amarin Corporation media release, in Argentina the primary and/or other endpoints of the study has not meet.
16 Nov 2021 According to an Amarin Corporation media release, data from this trial was presented in a Rapid Fire Oral Session Presentation at the American Heart Association (AHA) Scientific Sessions 2021.
16 Nov 2021 Results presented in an Amarin Corporation media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com